Skip to ContentSkip to Navigation
breed in kennis  -  sterk in techniek
Over ons Praktische zaken Waar vindt u ons dr. S.F. Oosting

Publicaties

ESMO Adaptation of Lines of Systemic Therapy (EnLiST): a consensus framework for standardising the designation of lines of therapy in solid tumours

Fumarate hydratase-deficient renal cell carcinoma - results of the exploratory analysis in the SUNNIFORECAST trial comparing Ipilimumab plus Nivolumab vs standard of care as first line treatment

Impact of Proton versus Photon (Chemo)radiation on Circulating Immune Cells in Head and Neck Cancer

Papillary renal cell carcinoma - exploratory results of the SUNNIFORECAST trial comparing Ipilimumab plus Nivolumab vs standard of care as first line therapy based on central pathological review

Programmed death ligand 1 (PD-L1) PET/CT imaging to evaluate tumour saturation during atezolizumab treatment

Real-world effectiveness of molecular-matched therapies in salivary gland cancer

Reporting health-related quality of life in randomised clinical trials evaluating adjuvant systemic therapy:: recommendations of Common-Sense Oncology and the European Organisation for Research and Treatment of Cancer

Standardization of objectives and response criteria for neoadjuvant immunotherapy in resectable squamous cell carcinoma of the head and neck

Tremelimumab with or without durvalumab in combination with paclitaxel in metastatic urothelial cancer: phase I/II ICRA trial

Comparison of White Light With Narrow Band Imaging Using Flexible Laryngoscopy for the Detection of Local Recurrences After (Chemo)Radiation for Pharyngeal or Laryngeal Cancer: A Randomised Controlled Trial

Pers/media

Sustainable Development Goals

SDG 3 – Goede gezondheid en welzijnSDG 5 – GendergelijkheidSDG 9 – Industrie, innovatie en infrastructuurSDG 10 – Minder ongelijkheid

Meer informatie over de Sustainable Development Goals.